levonorgestrel has been researched along with Vaginitis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dawood, R; Masood, A; Rezk, M; Sayyed, T | 1 |
Bellen, G; Berger, J; Cornelis, A; Donders, GG; Heuninckx, H | 1 |
Bahamondes, L; Discacciati, MG; Hidalgo, M; Lessard, T; Simões, JA | 1 |
Roy, S | 1 |
Grubb, GS; Klavon, SL | 1 |
1 review(s) available for levonorgestrel and Vaginitis
Article | Year |
---|---|
Nonbarrier contraceptives and vaginitis and vaginosis.
Topics: Candidiasis, Vulvovaginal; Contraceptive Devices, Female; Contraceptives, Oral; Female; Humans; Incidence; Intrauterine Devices; Levonorgestrel; Logistic Models; Odds Ratio; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial | 1991 |
5 other study(ies) available for levonorgestrel and Vaginitis
Article | Year |
---|---|
Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS.
Topics: Adult; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Prospective Studies; Trichomonas vaginalis; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial; Young Adult | 2017 |
Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device.
Topics: Candida; Candidiasis; Chi-Square Distribution; Cohort Studies; Contraception; Contraceptive Agents, Female; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mobiluncus; Papanicolaou Test; Pilot Projects; Retrospective Studies; Vagina; Vaginal Smears; Vaginitis; Vaginosis, Bacterial | 2011 |
Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS).
Topics: Adolescent; Adult; Brazil; Cervix Uteri; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Vagina; Vaginal Smears; Vaginitis | 2008 |
Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
Topics: Abdominal Pain; Adult; Breast Neoplasms; Contraceptive Agents, Female; Developing Countries; Drug Implants; Female; Fertility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Marital Status; Ovarian Cysts; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Prospective Studies; Sterilization, Tubal; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vaginal Discharge; Vaginitis | 2001 |
Insertion site complications during the first year of NORPLANT use.
Topics: Adult; Contraceptive Agents, Female; Demography; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Norgestrel; Vaginitis | 1990 |